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Determinants of glycosylation site usage were explored by using the hemagglutinin-neuraminidase (HN)
glycoprotein of the paramyxovirus Newcastle disease virus. The amino acid sequence of the HN protein, a type
II glycoprotein, has six N-linked glycosylation addition sites, G1 to G6, two of which, G5 and G6, are not used
for the addition of carbohydrate (L. McGinnes and T. Morrison, Virology 212:398–410, 1995). The sequence of
this protein also has 13 cysteine residues in the ectodomain (C2 to C14). Mutation of either cysteine 13 or
cysteine 14 resulted in the addition of another oligosaccharide chain to the protein. These cysteine residues
flank the normally unused G6 glycosylation addition site, and mutation of the G6 site eliminated the extra
glycosylation found in the cysteine mutants. These results suggested that failure to form an intramolecular
disulfide bond resulted in the usage of a normally unused glycosylation site. This conclusion was confirmed by
preventing cotranslational disulfide bond formation in cells by using dithiothreitol. Under these conditions, the
wild-type protein acquired extra glycosylation, which was eliminated by mutation of the G6 site. These results
suggest that localized folding events on the nascent chain, such as disulfide bond formation, which block access
to the oligosaccharyl transferase are a determinant of glycosylation site usage.
N-linked glycosylation, a common modification of viral gly-
coproteins as well as cellular plasma membrane and secreted
proteins, plays various roles in the folding, stability, and bio-
logical activity of proteins and is an important component of
their structure and function (13, 30). The core oligosaccharide
chains are preassembled on the carrier lipid, dolichol phos-
phate, in the rough endoplasmic reticulum (RER) and are
then covalently attached through the action of oligosaccharyl
transferase to polypeptides at asparagines in the sequence
NXT or NXS, where X is any amino acid except proline (13).
The core oligosaccharide is covalently attached to the nascent
polypeptide very soon after the asparagine emerges from the
translocation channel into the lumen of the RER (6, 13).
Indeed, oligosaccharyl transferase is thought to be closely as-
sociated with the translocation machinery (6).
Not all NXT or NXS motifs in a protein sequence, however,
are used for carbohydrate addition. There are numerous ex-
amples in the literature of proteins which remain unglycosy-
lated at specific sites or are inefficiently glycosylated at specific
sites while other sites are always utilized (30). The reasons for
usage of some carbohydrate addition signals but not others are
poorly understood; however, the failure to use specific addition
signals suggests that there are elements, in addition to the
3-amino-acid sequence motif, involved in the recognition of a
site for glycosylation. That there are no other recognized pri-
mary sequence motifs associated with N-linked glycosylation
suggests the hypothesis that secondary structures on the nas-
cent chain influence usage of glycosylation addition sites.
To test this possibility, we have explored determinants of
glycosylation site usage in a viral glycoprotein, the Newcastle
disease virus (NDV) hemagglutinin-neuraminidase (HN) pro-
tein, which has two unused glycosylation addition signals (17).
The HN protein, a member of a family of proteins which are
the attachment proteins of paramyxoviruses (24), is a type II
glycoprotein with a 26-amino-acid amino-terminal cytoplasmic
domain, a 22-amino-acid signal-anchor domain, and a 523-
amino-acid ectodomain (24). The primary sequence has six
glycosylation addition signals in the ectodomain (G1 to G6,
numbered from the amino terminus of the protein) (19); how-
ever, only four sites (G1 to G4) are used for glycosylation (17).
The protein also has 13 cysteine residues (C2 to C14) in the
ectodomain (19). One of these, the cysteine residue closest to
the membrane anchor (C2, at amino acid 123), is involved in
intermolecular disulfide bond formation (22, 23), while the
other 12 cysteine residues are involved in intramolecular di-
sulfide bond formation (22). In characterizing the role of in-
dividual cysteine residues in protein maturation, we found
evidence suggesting that intramolecular disulfide bond forma-
tion might play a role in glycosylation site usage (22). We
report here that mutation of either of two likely linked cysteine
residues allows the usage of a normally unutilized glycosylation
addition signal. Furthermore, inhibition of cotranslational di-
sulfide bond formation on the nascent chain also allows the
usage of that site in the wild-type protein. Results suggest that
cotranslational disulfide bond formation blocks access of oli-
gosaccharyl transferase to the addition site.
MATERIALS AND METHODS
Cells, vectors, and viruses. Cos-7 cells, obtained from the American Type
Culture Collection, were maintained in Dulbecco’s modified Eagle medium
supplemented with nonessential amino acids, vitamins, glutamine, penicillin,
streptomycin, and 10% fetal calf serum.
The NDVHN gene (25, 26) was expressed in Cos cells by using pSVL obtained
from Pharmacia (32).
NDV strain AV was purified after growth in embryonated chicken eggs by
standard protocols.
Antibodies. The antibody used to detect antigenically mature HN protein was
an anti-NDV antibody raised in rabbits against UV-inactivated NDV virions
(strain AV) by standard protocols (32). This antibody reacts with mature HN
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protein but not with nascent protein (22, 32). Monoclonal antibodies specific for
the NDV HN protein were the generous gift of Ron Iorio. Antibodies used were
anti-2b, anti-4a, and anti-14c (7–10). These monoclonal antibodies also react
only to mature protein (20). The antibody used to detect the nascent or unfolded
HN protein was a mix of rabbit antibody raised against the AluI-to-SmaI frag-
ment (amino acids 117 to 515) (anti-AS) of the HN gene expressed in bacteria as
a TrpE fusion protein and anti-AC, a rabbit antibody raised against the AluI-
to-ClaI fragment (amino acids 117 to 268) of the HN protein expressed as a TrpE
fusion protein (32).
Site-specific mutagenesis. Mutant genes were derived by using the Scultor
mutagenesis kit (Amersham Co.). The appropriate oligomers, 15 to 18 nucleo-
tides in length, were used in the mutagenesis reactions to make the changes
shown in Fig. 1B and C. All mutant DNAs were sequenced in their entirety to
verify that the rest of the gene was unchanged in the mutagenesis reactions.
Infections. Cos cells were infected with NDV at a multiplicity of infection of
15, as previously described (20). Labeling with [35S]methionine was accom-
plished at 5 to 6 h posttransfection as previously described, and cell extracts were
prepared as described below.
Transfections. Transfections using DEAE-dextran and chloroquine were done
essentially as previously described (14, 32). Cos cells were incubated with a mix
consisting of 0.25 ml of Tris-buffered saline (25 mM Tris, 136 mM NaCl, 5 mM
KCl, 0.7 mM Na2HPO4 [pH 7.4]), 1.25 ml of DEAE-dextran (100 mg/ml) in 0.15
M Tris-HCl (pH 7.5), and 1 mg of DNA for 30 min at 378C. The DNA-dextran
mix was replaced with chloroquine (100 mM final concentration) in 2 ml of
OptiMem, and the cells were incubated for 4 to 5 h at 378C. The chloroquine was
replaced with 2 ml of Cos medium.
Radiolabeling and immunoprecipitation of protein. Transfected or infected
cells were radiolabeled at 378C in Dulbecco modified Eagle medium lacking
methionine but containing 100 mCi of [35S]methionine (Amersham) per ml. At
the end of the labeling period, cells were washed in phosphate-buffered saline
and lysed in reticulocyte standard buffer (0.01 M Tris-HCl [pH 7.4]–0.01 M
NaCl) containing 1% Triton X-100, 0.5% sodium deoxycholate, 10 mM iodoac-
etamide, 10 mM N-ethylmaleimide, 40 mU of hexokinase, 20 mM glucose, and
2 mM CaCl2 as previously described (18, 22, 28). Nuclei were removed by
centrifugation. Immunoprecipitation of NDV proteins was accomplished as pre-
viously described (22, 27).
Endoglycosidase H digestion. Cells transfected with wild-type or mutant
DNAs were radioactively labeled for 2 h and chased with nonradioactive medium
for 2 h. HN proteins were precipitated with a mix of anti-AC/AS and anti-NDV
antibodies. The precipitated protein was resuspended in buffer H (1% sodium
dodecyl sulfate–0.150 M Tris-HCl [pH 7.5]) and boiled for 5 min. Phenylmeth-
ylsulfonyl fluoride (final concentration, 3 mM) and citrate buffer (pH 5.5; final
concentration, 0.1 M) were added. Endoglycosidase H (endo H) (1.5 mU; Boehr-
inger Mannheim) was added to half the sample, and the sample was incubated
for 24 h at 378C.
RESULTS
Glycosylation of the HN protein with mutations in cysteine
residues. That intramolecular disulfide bond formation might
influence glycosylation of the HN protein was suggested from
properties of mutants with alterations in cysteine residues (22).
The approximate locations of the 13 cysteine residues in the
linear sequence of the ectodomain of the HN protein (19) are
diagramed in Fig. 1A. Characterization of the expression of
proteins with alterations in each of the cysteine residues re-
vealed that mutation of either cysteine 13 or cysteine 14 (Fig.
1C) resulted in two polypeptides, one which comigrated with
the wild-type protein and one which was approximately 3 kDa
larger than the wild-type protein (22) (Fig. 2, lanes 5 and 9).
Similar results were obtained with the mutant C14a, in which
cysteine 14 was eliminated and the glycosylation addition site
was moved slightly (Fig. 2, lane 11). That the increased mo-
lecular size of the larger species was due to glycosylation is
shown by digestion of the proteins with endo H. Labeling
conditions were such that the wild-type protein was a mixture
of endo H-sensitive and -resistant forms and proteins were
precipitated with a mix of antibodies specific for both mature
and nascent protein. It has been previously shown that the
mature form of the HN protein is partially resistant to endo H,
thus migrating slightly faster than the undigested control (31)
(Fig. 2, lane 4, top band). The C13 and C14 mutations block
maturation of the protein (22); thus, the proteins contained no
FIG. 1. Primary structure of the HN protein and mutants of the HN protein.
(A) Linear diagram of the primary sequence of the HN glycoprotein, with the
positions of the cysteine residues and glycosylation addition sites marked. TM,
transmembrane. (B) Primary sequence in the region of cysteines 13 and 14. (C)
Amino acid changes in the individual mutants. 1, no change.
FIG. 2. Expression of wild-type and mutant proteins. Cos cells transfected
with wild-type and mutant proteins were radioactively labeled with [35S]methi-
onine for 2 h at 48 h posttransfection. Proteins present in cell extracts were
precipitated with a mix of anti-NDV, anti-AC, and anti-AS antibodies, and the
resulting precipitated proteins were digested (1) or mock digested (2) with
endo H and then electrophoresed on 10% polyacrylamide gels in the presence of
reducing agent. Mutant DNAs are indicated at the top of the figure in lanes 5
through 14. v, vector-transfected cells; wt, wild-type DNA; m, marker proteins
from NDV-infected cells; NP, nucleocapsid protein; M, membrane protein.
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partially resistant material. The endo H-sensitive forms of both
mutant and wild-type proteins comigrated, as is shown in Fig.
2 (lanes 4, 6, 10, and 12). Thus, the increased molecular size of
C13 and C14 mutant proteins was due to altered glycosylation.
The minor band migrating just below the undigested and
digested HN protein was likely due to initiation of protein
synthesis at a methionine located just within the transmem-
brane domain of the protein (17, 19). It is seen in reticulocyte
cell-free translation product made in the absence of mem-
branes (data not shown).
Glycosylation site usage in cysteine mutants. One interpre-
tation of the altered glycosylation of the mutant HN protein is
that elimination of either cysteine residue 13 or cysteine resi-
due 14 allows the glycosylation of a normally unused glycosyl-
ation addition site. The HN protein of the AV strain of NDV
has six glycosylation addition sites in its sequence (19), the
positions of which are shown in Fig. 1A. Glycosylation addition
sites 1, 2, 3, and 4 are used, while sites 5 and 6 are not used
(17). One of the unused sites, G6, is located between cysteine
residues 13 and 14 (Fig. 1A and B), suggesting that failure to
form an intramolecular disulfide bond using cysteine 13 or 14
might make a normally inaccessible glycosylation site 6 acces-
sible to oligosaccharyl transferase. To test this idea, double
mutants were constructed which combined mutation of glyco-
sylation site 6 with a mutation in either cysteine 13 or cysteine
14 (Fig. 1C). Both double mutants resulted in only one
polypeptide, which comigrated with the wild-type protein (Fig.
2, lanes 7 and 13). Thus, the elimination of site 6 eliminated
the larger-molecular-size species found in proteins with a mu-
tation in cysteine 13 or 14.
Endo H digestion of these double mutants also resulted in a
polypeptide which comigrated with endo H-digested wild-type
protein (Fig. 2, lanes 8 and 14). This result shows that only the
glycosylation of the C13 and C14 mutant proteins has been
altered by the G6 mutation. Proteolytic cleavage cannot ac-
count for the decrease in molecular size of the protein.
The amount of total mutant HN protein synthesized that
was glycosylated at site 6 ranged between 59 and 39% (Table
1). The C13 mutant protein consistently contained more gly-
cosylation at site 6 than the C14 mutant protein, while the
C14a mutant protein contained only slightly lower amounts
than the C13 mutant protein.
Glycosylation site usage under reducing conditions. The
results above suggest that failure to form intramolecular disul-
fide bonds using cysteine 13 or 14 resulted in the usage of a
normally unused glycosylation addition site 6. Thus, if intramo-
lecular disulfide bond formation is inhibited during the expres-
sion of the wild-type protein, it would be predicted that glyco-
sylation site 6 would be utilized. It has been previously shown
that treatment of cells with dithiothreitol (DTT) results in the
synthesis of an unfolded protein without intramolecular disul-
fide bonds (3, 16, 33). Formation of intramolecular disulfide
bonds and, therefore, folding of the molecule can occur only
after removal of DTT (3, 16, 33).
To determine if DTT treatment of HN protein-expressing
cells blocks intramolecular disulfide bond formation and, there-
fore, folding, monoclonal antibodies which react only with the
mature, folded form of HN protein (20, 22) were used to
precipitate proteins from DTT-treated and untreated cells. We
have previously shown that representative monoclonal anti-
bodies to six different sites on the HN protein do not react to
nascent HN protein (20), as illustrated in Fig. 3, lanes 1, 7, and
13, for three of these antibodies. Reactivity appears as the
protein matures (20) (Fig. 3, lanes 2, 3, 8, 9, 14, and 15).
However, the HN protein synthesized in cells incubated in 5
mM DTT and chased in the presence of DTT remained anti-
genically immature and unreactive to the antibodies (Fig. 3,
lanes 5, 6, 11, 12, 17, and 18). Infected cells were used in order
to label significant amounts of protein in a 5-min pulse-label-
ing. Thus, DTT treatment of cells expressing the HN protein
also blocked the maturation of this glycoprotein, a result con-
sistent with inhibition of disulfide bond formation.
The protein synthesized in the presence of DTT and precip-
itated with antibody specific for nascent protein resolved into
two bands (Fig. 4B, lane 2), while the wild-type protein simi-
larly labeled in the absence of DTT migrated as a single band
(Fig. 4A, lane 2). In several experiments, 26 to 27% of the total
HN protein was found in a species which migrated with a
molecular size approximately 3 kDa larger than that of protein
made in the absence of DTT. The results presented above lead
to the hypothesis that it was usage of site 6 that was responsible
for the higher-molecular-size polypeptide seen in DTT-treated
cells. To explore this hypothesis, proteins mutated in each of
TABLE 1. Quantitation of amounts of mutant HN protein
glycosylated at site 6
DNAa HNab HNbb
% of total HN
glycosylated at
site 6c
Expt 1
C13S 37 55 59
C14S 64 66 51
Expt 2
C13S 58 56 49
C14S 99 62 39
C14Sa 81 68 46
Expt 3
C13S 49 65 57
C14S 91 71 44
C14a 71 58 56
a Experiments were performed with a mix of antibodies.
bMeasured as densitometer units. HNa, HN glycosylated at sites G1 to G4;
HNb, HN glycosylated at sites G1 to G4 and G6.
c Calculated as HNb/(HNa 1 HNb) 3 100.
FIG. 3. Incubation of cells with DTT blocks folding of the HN protein. Cells
infected with NDV were pulse-labeled (p) with [35S]methionine for 5 min and
then chased (c) in nonradioactive medium. Precipitates shown in lanes 1 to 3, 7
to 9, and 13 to 15 were from cells not treated with DTT (2), while precipitates
shown in lanes 4 to 6, 10 to 12, and 16 to 18 were from cells treated with 5 mM
DTT during both the pulse-labeling and the chase (1). Nonradioactive chases
were for 1 h (lanes 2, 5, 8, 11, 14, and 17) or 2 h (lanes 3, 6, 9, 12, 15, and 18).
Proteins present in the resulting cell extracts were precipitated with anti-4a
(lanes 1 to 6), anti-14c (lanes 7 to 12), or anti-2b (lanes 13 to 18). The resulting
precipitated proteins were electrophoresed in the presence of reducing agent on
10% polyacrylamide gels. m, marker proteins from infected cell extracts; NP,
nucleocapsid protein; M, membrane protein.
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the six glycosylation addition sites were synthesized in the
presence of DTT and then precipitated with antibody specific
for immature protein. Clearly, all expressed proteins resolved
into two species, except the protein with a mutation in site 6
(Fig. 4B, lane 8), showing that it was indeed utilization of site
6 that accounted for the additional carbohydrate in the pres-
ence of DTT. Thus, prevention of intramolecular disulfide
bond formation by DTT, as well as by mutation, resulted in the
usage of the normally unused glycosylation site 6.
Interestingly, these results show that inhibition of intramo-
lecular disulfide bond formation with DTT did not appear to
increase the usage of the G5 site. There was no species of HN
protein made in the presence of DTT that was eliminated by
mutating the G5 addition site.
Folding of the HN protein glycosylated at site 6. Previous
characterization of proteins with mutations in cysteine 13 or 14
showed that these proteins failed to fold properly (22). It
seemed possible that glycosylation at site 6 was at least partially
responsible for this folding defect. We therefore determined if
removal of glycosylation site 6 facilitated the folding of C13 or
C14 mutant proteins. Folding was monitored by reactivity of
the proteins to conformationally sensitive monoclonal antibod-
ies (20) (Fig. 5). As previously reported, mutants C13 and C14
failed to acquire mature antigenic sites (Fig. 5, lanes 3 and 5).
The elimination of site 6 in these mutants did not restore the
ability of these mutants to fold, since the double mutants
C13,G6 and C14,G6 also failed to acquire mature antigenic
determinants (Fig. 5, lanes 4 and 6). Failure to fold could not
be attributed to the mutation in site 6, since a protein defective
only in site 6 did acquire mature antigenic sites (Fig. 5, lane 7).
Thus, it is likely that the failure to form the disulfide bond,
rather than the secondary effect of glycosylation, is inhibitory
to maturation. This conclusion is supported by the observation
(Fig. 2) that the double mutants do not acquire endo H partial
resistance, as does the wild-type protein.
The effect of glycosylation at site 6 on maturation of the
wild-type protein was explored by characterizing the antigenic
sites formed on the protein synthesized in the presence of DTT
and chased in the absence of DTT to allow posttranslational
disulfide bond formation. In material precipitated by four dif-
ferent conformationally sensitive monoclonal antibodies, a
double band was resolved, suggesting that the protein species
glycosylated at site 6 formed antigenic sites, as did the faster-
migrating protein not glycosylated at this position (Fig. 5, lane
9). Table 2 shows a quantitation of the amount of material
present in both species after precipitation with different anti-
bodies. The ratio of protein glycosylated at site 6 to protein not
glycosylated in this position was similar for all antibodies.
However, in another study (21), we have shown that while the
HN protein synthesized in the presence of DTT and then
allowed to fold after removal of DTT acquires conformation-
ally sensitive antigenic sites, the protein is folded in a different
sequence and shows no biological activity (21). This result
suggests that the conformation of the protein folded after
removal of DTT is abnormal. This abnormal folding cannot,
however, be attributed to glycosylation at site 6, since HN
protein not glycosylated at site 6 is abnormally folded.
DISCUSSION
The results presented above show that a normally unused
glycosylation addition site in the sequence of the HN protein of
NDV is likely not used because intramolecular disulfide bond
formation in the vicinity of the site interferes with the addition
of the oligosaccharide. Usage of the site can occur when either
of two nearby cysteine residues is mutated or by inhibition of
cotranslational disulfide bond formation. Mutation of either
cysteine residue resulted in, on average, approximately 50% of
the protein being glycosylated at site 6, while inhibition of
cotranslational disulfide bond formation resulted in usage of
the site in 26 to 27% of the molecules.
The intramolecular disulfide bonds in paramyxovirus attach-
FIG. 4. Electrophoresis of nascent wild-type and mutant proteins made in the presence or absence of DTT. Cos cells transfected with wild-type (lane 2) or mutant
(lanes 3 to 8) DNAs were radioactively labeled with [35S]methionine for 1 h in the absence (A) or presence (B) of 5 mM DTT. Proteins present in the resulting cell
extracts were precipitated with a mix of anti-AC and anti-AS antibodies, and the resulting precipitated protein was electrophoresed on polyacrylamide gels in the
presence of reducing agent. Panel A was exposed to film for 1 day, and panel B was exposed for 2 days to compensate for the reduction in incorporation due to DTT
(3, 16, 33). m, marker proteins present in total infected cell extracts; v, vector-transfected cells; wt, wild-type DNA; NP, nucleocapsid protein; M, membrane protein.
The arrow indicates the polypeptide glycosylated at site 6. As previously described (17), elimination of carbohydrate at the G1 position results in a protein which
migrates slightly slower than protein missing either the G2, the G3, or the G4 oligosaccharide but faster than the fully glycosylated protein.
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ment proteins have not yet been defined. However, based on
comparisons of sequences, Colman et al. (5) have proposed
that this family of proteins is folded in much the same way as
the influenza neuraminidase glycoprotein, a protein whose
crystal structure and intramolecular disulfide bonds have been
defined (4). Based on the comparison, Colman et al. have
proposed that cysteine residues 13 and 14 are linked (5). In-
deed, we have shown that cysteine 13 and cysteine 14 mutants
have similar phenotypes, which are different from those of
proteins with mutations in other cysteine residues (22), a find-
ing which strongly supports the idea that these two residues are
linked.
Linkage of cysteines 13 and 14 would provide an explanation
for their role in the usage of glycosylation site 6. It has been
shown by Nilsson and von Heijne (29) that oligosaccharyl
transferase can transfer oligosaccharides to nascent polypep-
tide chains only after the addition site is 30 to 40 Å from the
RERmembrane or after 12 to 14 amino acids carboxy-terminal
to the site have emerged into the lumen of the RER, as dia-
gramed in Fig. 6A. Given these results, folding events in the
region of a glycosylation site which occur on the nascent chain
before the site is 12 to 14 amino acids from the RER mem-
brane might have the potential to block oligosaccharide addi-
tion. Intramolecular disulfide bond formation might be such a
folding event. Indeed, cysteine 14 is only 4 amino acids from
site 6. If cysteines 13 and 14 link immediately after cysteine 14
has emerged from the translocation channel, the linkage would
occur prior to accessibility of the glycosylation site to the trans-
ferase, as diagramed in Fig. 6C. Formation of the intramolec-
ular disulfide bond would serve to sequester the site, prevent-
ing its usage (Fig. 6D). Indeed, we have previously reported
that mutations in cysteine 13 or 14 block maturation of the HN
protein very early in a folding sequence (22), results consistent
with cotranslational formation of this disulfide bond.
There are reports in the literature suggesting that intramo-
lecular disulfide bond formation may influence glycosylation
site usage in other proteins. Kane suggested that an unused site
in procathepsin L is not used because of a nearby intramolec-
ular disulfide bond (11). Allen et al. (1) showed that an inef-
ficiently used glycosylation addition site in plasminogen acti-
vator is more efficiently used if intramolecular disulfide bond
formation is inhibited with DTT. A survey of the literature,
however, makes it clear that the restriction of glycosylation site
usage cannot always be attributed to disulfide bond formation.
There are examples of unused sites very distant from cysteine
residues. Indeed, glycosylation site 5 in the HN sequence is not
located near cysteine residues, nor was this site used if in-
tramolecular disulfide bond formation was inhibited. Thus, a
more general hypothesis for the failure to use sites is that
localized folding events on the nascent chain which block ac-
cess of the oligosaccharyl transferase to the site are a deter-
minant of glycosylation site usage. Disulfide bond formation
may be only one such folding event. For example, Altmann et
FIG. 5. Maturation of mutant and wild-type polypeptides. Cos cells trans-
fected with wild-type or mutant DNAs were radioactively labeled with [35S]me-
thionine for 15 min in the absence (lanes 1 to 6) or presence (lanes 8 and 9) of
DTT and then chased for 2 h in nonradioactive medium without DTT. Proteins
present in the resulting cell extracts were precipitated with anti-4a (A), anti-14c
(B), anti-3a (C), and anti-2b (D). v, vector-transfected cells; wt, wild-type DNA.
TABLE 2. Quantitation of amounts of wild-type HN protein
glycosylated at site 6 in the presence of DTT
Antibody HNaa HNba
% of total HN
glycosylated at
site 6b
Expt 1, anti-AC/AS 108 40 27
Expt 2, anti-AC/AS 75 27 26
Expt 3
Anti-4 61 18 22
Anti-14 84 26 24
Anti-3 43 13 23
Anti-2 61 18 23
aMeasured as densitometer units. HNa, HN glycosylated at sites G1 to G4;
HNb, HN glycosylated at sites G1 to G4 and G6.
b Calculated as HNb/(HNa 1 HNb) 3 100.
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al. (2) showed that introduction of prolines into predicted a
helices resulted in hyperglycosylation of murine granulocyte-
macrophage colony-stimulating factor and speculated that a
more relaxed conformation of a nascent chain allows greater
exposure of Asn residues to oligosaccharyl transferase.
Unused glycosylation sites may also be located in specific
regions of the nascent chain which interact with other ER
proteins, blocking access to oligosaccharyl transferase. Livi et
al. (15) have reported that a glycosylation addition site close to
the signal sequence cleavage site is not used and suggest that
signal peptidase can block access of oligosaccharyl transferase
to the amino terminus of the nascent chain. Kim and Cunning-
ham (12) have shown that the murine retrovirus Env protein
can bind to its receptor molecule in the RER, preventing
glycosylation at a specific site.
Inhibition of the disulfide bond by synthesis of protein in the
presence of DTT or by mutation resulted in the usage of site 6
in approximately 26 to 59%, respectively, of the molecules
made in the cell. Clearly, the site was not used at 100% effi-
ciency under either of these conditions. Thus, it is likely that
there is some folding of this region of the nascent chain, inde-
pendent of disulfide bond formation, which decreases the ef-
ficiency of glycosylation at site 6. Indeed, this region must be
folded in such a way as to place the cysteine residues in prox-
imity. This folding may decrease the accessibility of the site to
oligosaccharyl transferase, resulting in less than 100% effi-
ciency of usage. Consistently, the site was used more efficiently
in mutant proteins than in wild-type protein made in the pres-
ence of DTT. Perhaps single amino acid changes present in the
mutants affect the folding in this region of the molecule, in-
creasing the accessibility of the site to oligosaccharyl trans-
ferase.
ACKNOWLEDGMENTS
This work was supported by grant GM37745 from the National
Institutes of Health.
We thank R. Iorio for the gift of monoclonal antibodies.
REFERENCES
1. Allen, S., H. Y. Naim, and N. J. Bulleid. 1994. Intracellular folding of
tissue-type plasminogen activator. J. Biol. Chem. 270:4797–4804.
2. Altmann, S. W., G. D. Johnson, and M. B. Prystowky. 1991. Single proline
substitutions in predicted a helices of murine granulocyte-macrophage col-
ony stimulating factor result in a loss of bioactivity and altered glycosylation.
J. Biol. Chem. 266:5333–5341.
3. Braakman, I., J. Helenius, and A. Helenius. 1992. Manipulating disulfide
bond formation and protein folding in the endoplasmic reticulum. EMBO J.
11:1717–1722.
4. Colman, P. M. 1989. Influenza virus neuraminidase: enzyme and antigen, p.
175–218. In R. M. Krug (ed.), The influenza viruses. Plenum Publishing
Corp., New York, N.Y.
5. Colman, P. M., P. A. Hoyne, and M. C. Lawrence. 1993. Sequence and
structure alignment of paramyxovirus hemagglutinin-neuraminidase with in-
fluenza virus neuraminidase. J. Virol. 67:2972–2980.
6. Gilmore, R. 1993. Protein translocation across the endoplasmic reticulum: a
tunnel with toll booths at entry and exit. Cell 75:589–592.
7. Iorio, R. M., R. L. Glickman, A. M. Riel, J. P. Sheehan, and M. A. Bratt.
1989. Functional and neutralization profile of seven overlapping antigenic
sites on the HN glycoprotein of Newcastle disease virus: monoclonal anti-
bodies to some sites prevent viral attachment. Virus Res. 13:245–262.
8. Iorio, R. M., R. L. Glickman, A. M. Riel, J. P. Sheehan, and M. A. Bratt.
1989. Identification of amino acid residues important to the neuramini-
dase activity of the glycoprotein of Newcastle disease virus. Virology
173:196–204.
9. Iorio, R. M., R. L. Glickman, and J. P. Sheehan. 1992. Inhibition of fusion
by neutralizing monoclonal antibodies of the hemagglutinin-neuraminidase
glycoprotein of Newcastle disease virus. J. Gen. Virol. 73:1167–1176.
10. Iorio, R. M., R. J. Syddall, R. L. Glickman, A. M. Riel, J. P. Sheehan, and
M. A. Bratt. 1991. Neutralization map of the hemagglutinin-neuraminidase
glycoprotein of Newcastle disease virus: domains recognized by monoclonal
antibodies that prevent receptor recognition. J. Virol. 65:4999–5006.
11. Kane, S. E. 1993. Mouse procathepsin L lacking a functional glycosylation
FIG. 6. Proposed mechanism for failure to use glycosylation site 6. (A) The active site of oligosaccharyl transferase (OST) is positioned such that the glycosylation
addition site is recognized only when 12 to 13 amino acids have emerged from the translocation pore, as proposed by Nilsson and von Heijne (29). (B) Cysteine 13
and then glycosylation site 6 emerge from the translocation pore, followed by cysteine 14. (C) Upon the appearance of cysteine 14, a disulfide bond forms. (D)
Translocation proceeds, but folding blocks access of the oligosaccharyl transferase to the glycosylation addition site.
3088 MCGINNES AND MORRISON J. VIROL.
 at UNIV O
F M
ASS M
ED SCH on August 4, 2008 
jvi.asm.org
D
ow
nloaded from
 
site is properly folded, stable, and secreted by NIH 3T3 cells. J. Biol. Chem.
268:11456–11462.
12. Kim, J. W., and J. M. Cunningham. 1993. N linked glycosylation of receptor
for murine ecotropic retrovirus is altered in virus infected cells. J. Biol.
Chem. 268:16316–16320.
13. Kornfeld, R., and S. Kornfeld. 1985. Assembly of asparagine-linked oligo-
saccharides. Annu. Rev. Biochem. 54:631–664.
14. Levesque, J.-P., P. Sanilvestri, A. Hatzfeld, and J. Hatzfeld. 1991. DNA
transfection in Cos cells: a low cost serum free method compared to Lipo-
fectin. BioTechniques 11:313–318.
15. Livi, G. P., J. S. Lillquist, L. M. Miles, A. Ferrara, G. M. Sathe, P. L. Simon,
C. A. Meyers, J. A. Gorman, and P. R. Young. 1991. Secretion of N-glyco-
sylated interleukin-1b in Saccharomyces cerevisiae using a leader peptide
from Candida albicans. J. Biol. Chem. 266:15348–15355.
16. Lodish, H. F., and N. Kong. 1993. The secretory pathway is normal in
dithiothreitol-treated cells, but disulfide-bonded proteins are reduced and
reversibly retained in the endoplasmic reticulum. J. Biol. Chem. 268:20598–
20605.
17. McGinnes, L., and T. Morrison. 1995. Role of individual oligosaccharide
chains in the maturation and activities of the HN protein of NDV. Virology
212:398–410.
18. McGinnes, L., T. Sergel, and T. G. Morrison. 1993. Mutations in the trans-
membrane domain of the HN protein of Newcastle disease virus affect the
structure and activity of the protein. Virology 196:101–110.
19. McGinnes, L., A. Wilde, and T. Morrison. 1987. Nucleotide sequence of the
gene encoding the Newcastle disease virus hemagglutinin-neuraminidase
protein and comparisons of paramyxovirus hemagglutinin-neuraminidase
sequences. Virus Res. 7:187–202.
20. McGinnes, L. W., and T. G. Morrison. 1994. Conformationally sensitive
antigenic determinants on the HN glycoprotein of Newcastle disease virus
form with different kinetics. Virology 199:255–264.
21. McGinnes, L. W., and T. G. Morrison. 1996. Role of cotranslational disulfide
bond formation in the folding of the hemagglutinin-neuraminidase protein
of Newcastle disease virus. Virology 224:465–476.
22. McGinnes, L. W., and T. G. Morrison. 1994. The role of the individual
cysteine residues in the formation of the mature, antigenic HN protein of
Newcastle disease virus. Virology 200:470–483.
23. Mirza, A. M., J. P. Sheehan, L. W. Hardy, R. L. Glickman, and R. M. Iorio.
1993. Structure and function of a membrane anchor-less form of the hem-
agglutinin-neuraminidase glycoprotein of Newcastle disease virus. J. Biol.
Chem. 268:21425–21431.
24. Morrison, T., and A. Portner. 1991. Structure, function, and intracellular
processing of the glycoproteins of Paramyxoviridae, p. 347–382. In D. Kings-
bury (ed.), The paramyxoviruses. Plenum Press, New York, N.Y.
25. Morrison, T. G., and L. W. McGinnes. 1989. Avian cells expressing the
Newcastle disease virus HN protein are resistant to NDV infection. Virology
171:10–17.
26. Morrison, T. G., C. McQuain, and L. McGinnes. 1991. Complementation
between avirulent Newcastle disease virus and a fusion protein expressed
from a retrovirus vector: requirements for membrane fusion. J. Virol. 65:
813–822.
27. Morrison, T. G., C. McQuain, K. F. O’Connell, and L. W. McGinnes. 1990.
Mature, cell-associated HN protein of Newcastle disease virus exists in two
forms differentiated by posttranslational modifications. Virus Res. 15:113–
134.
28. Morrison, T. G., L. Ward, and A. Semerjian. 1985. Intracellular processing
of the Newcastle disease virus fusion glycoprotein. J. Virol. 53:851–857.
29. Nilsson, I., and G. von Heijne. 1993. Determination of the distance between
the oligosaccharyltransferase active site and the endoplasmic reticulum
membrane. J. Biol. Chem. 268:5798–5801.
30. Rademacher, T. W., R. B. Parekh, and R. A. Dwek. 1988. Glycobiology.
Annu. Rev. Biochem. 57:786–830.
31. Schwalbe, J. C., and L. E. Hightower. 1982. Maturation of the envelope
glycoproteins of Newcastle disease virus on cellular membranes. J. Virol.
41:947–957.
32. Sergel, T., L. W. McGinnes, M. E. Peeples, and T. G. Morrison. 1993. The
attachment function of the Newcastle disease virus hemagglutinin-neuramin-
idase protein can be separated from fusion promotion by mutation. Virology
193:717–726.
33. Tatu, U., I. Braakman, and A. Helenius. 1993. Membrane glycoprotein
folding, oligomerization, and intracellular transport: effects of dithiothreitol
in living cells. EMBO J. 12:2151–2157.
VOL. 71, 1997 DETERMINANTS OF GLYCOSYLATION SITE USAGE 3089
 at UNIV O
F M
ASS M
ED SCH on August 4, 2008 
jvi.asm.org
D
ow
nloaded from
 
